The detection of GPC1 in pancreatic cancer exosomes exhibited a high specificity and sensitivity, which can be used to distinguish between patients with benign pancreatic disease and healthy individuals and between advanced‐stage pancreatic cancer and early‐stage pancreatic cancer 10. This evidence concerns the gene GPC1 and pancreatic neoplasm.